Heavy chain single-domain antibodies to detect native human soluble epoxide hydrolase

Anal Bioanal Chem. 2015 Sep;407(24):7275-83. doi: 10.1007/s00216-015-8889-6. Epub 2015 Jul 31.

Abstract

The soluble epoxide hydrolase (sEH) is a potential pharmacological target for treating hypertension, vascular inflammation, pain, cancer, and other diseases. However, there is not a simple, inexpensive, and reliable method to estimate levels of active sEH in tissues. Toward developing such an assay, a polyclonal variable domain of heavy chain antibody (VHH) sandwich immunoassay was developed. Ten VHHs, which are highly selective for native human sEH, were isolated from a phage-displayed library. The ten VHHs have no significant cross-reactivity with human microsomal epoxide hydrolase, rat and mouse sEH, and denatured human sEH. There is a high correlation between protein levels of the sEH determined by the enzyme-linked immunosorbent assay (ELISA) and the catalytic activity of the enzyme in S9 fractions of human tissues (liver, kidney, and lung). The VHH-based ELISA appears to be a new reliable method for monitoring the sEH and may be useful as a diagnostic tool for diseases influenced by sEH. This study also demonstrates the broad utility of VHH in biochemical and pharmacological research.

Keywords: ELISA; Magnetic beads; Soluble epoxide hydrolase; VHH; sEH.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Camelids, New World
  • Cross Reactions
  • Enzyme-Linked Immunosorbent Assay
  • Epoxide Hydrolases / analysis*
  • Epoxide Hydrolases / immunology
  • Humans
  • Molecular Sequence Data
  • Sequence Homology, Amino Acid
  • Single-Domain Antibodies / chemistry
  • Single-Domain Antibodies / immunology*

Substances

  • Single-Domain Antibodies
  • Epoxide Hydrolases